• 1
    Ferlay J,Bray F,Pisani P,Parkin DM. GLOBOCAN 2002: cancer incidence, mortality and prevalence worldwide. IARC CancerBase No. 5, version 2.0. Lyon: IARC Press, 2004.
  • 2
    Danaei G,Vander Hoorn S,Lopez AD,Murry CJ,Ezzati M. Causes of cancer in the world: comparative risk assessment of nine behavioural and environmental risk factors. Lancet 2005; 366: 178493.
  • 3
    Wilson JMG,Jungner G. Principles and practice of screening for disease. Geneva: World Health Organization Chronicle, 1968. Available at (accessed December 2008).
  • 4
    The Paris endoscopic classification of superficial neoplastic lesions: esophagus, stomach, and colon: November 30 to December 1, 2002. Gastrointest Endosc 2003; 58( 6, Suppl): S343.
  • 5
    Kudo S,Kashida H,Tamura T,Kogure E,Imai Y,Yamano H,Hart AR. Colonoscopic diagnosis and management of non polypoid early colorectal cancer. World J Surg 2000; 24: 108190.
  • 6
    Soetikno R,Friedland S,Kaltenbach T,Chayama K,Tanaka S. Nonpolypoid (flat and depressed) colorectal neoplasms. Gastroenterology 2006; 130: 56676.
  • 7
    Winawer SJ,Zauber AG,O'Brien MJ,Ho MN,Gottlieb L,Sternberg SS,Waye JD,Bond J,Schapiro M,Stewart ET,Panish J,Ackroyd F, et al. Randomized comparison of surveillance intervals after colonoscopic removal of newly diagnosed adenomatous polyps. The National Polyp Study Workgroup. N Engl J Med 1993; 328: 9016.
  • 8
    Winawer SJ,Zauber AG,Fletcher RH,Stillman JS,O'Brien MJ,Levin B,Smith RA,Lieberman DA,Burt RW,Levin TR,Bond JH,Brooks D, et al. Guidelines for colonoscopy surveillance after polypectomy: a consensus update by the US Multi-Society Task Force on Colorectal Cancer and the American Cancer Society. Gastroenterology 2006; 130: 187285.
  • 9
    Levin B,Lieberman DA,McFarland B,Andrews KS,Brooks D,Bond J,Dash C,Giardiello FM,Glick S,Johnson D,Johnson CD,Levin TR, et al. Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology. Gastroenterology 2008; 134: 157095.
  • 10
    Atkin WS. Flexible sigmoidoscopy as a mass screening tool. Eur J Gastroenterol Hepatol 1998; 10: 21923.
  • 11
    Weissfeld JL,Shoen RE,Pinsky PF,Bresalier RS,Church T,Yurgalevitch S,Austin JH,Prorok PC,Gohagan JK. Flexible sigmoidoscopy in the PLCO cancer screening trial: results from the baseline screening examination of a randomized trial. J Natl Cancer Inst 2005; 97: 98997.
  • 12
    Hewitson P,Glasziou P,Irwig L,Towler B,Watson E. Screening for colorectal cancer using the faecal occult blood test, Hemoccult. Cochrane Database Syst Rev 2007: CD001216.
  • 13
    Hewitson P,Glasziou P,Watson E,Towler B,Watson E. Cochrane systematic review of colorectal cancer screening using the fecal occult blood test (hemoccult): an update. Am J Gastroenterol 2008; 103: 15419.
    Direct Link:
  • 14
    Mandel JS,Church TR,Bond JH,Ederer F,Geisser MS,Mongin SJ,Snover DC,Schuman LM. The effect of fecal occult-blood screening on the incidence of colorectal cancer. N Engl J Med 2000; 343: 16037.
  • 15
    Surveillance, Epidemiology, and End Results (SEER) Program Public-Use (1973–1997), National Cancer Institute. Available at (accessed November 2008).
  • 16
    CuradoMP,EdwardsB,ShinHR,StormH,FerlayJ,HeanueM,BoyleP, eds. Cancer incidence in five continents, vol. 9.IARC Scientific Publications No. 160. Lyon: International Agency for Research on Cancer, 2007.
  • 17
    Tsoi KK,Ng SS,Leung MC,Sung JJ. Cost-effectiveness analysis on screening for colorectal neoplasm and management of colorectal cancer in Asia. Aliment Pharmacol Ther 2008; 28: 35363.
  • 18
    The WHO Global InfoBase. Impact of cancer. Available from: (accessed November 2008).
  • 19
    Bray F,McCarron P,Parkin DM. The changing global patterns of female breast cancer incidence and mortality. Breast Cancer Res 2004; 6: 22939.
  • 20
    Parkin DM,Bray F,Ferlay J,Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 2005; 55: 74108.
  • 21
    Sankaranarayanan R,Budukh AM,Rajkumar R. Effective screening programmes for cervical cancer in low- and middle-income developing countries. Bull World Health Organ 2001; 79: 95462.
  • 22
    Denny L,Quinn M,Sankaranarayanan R. Chapter 8: Screening for cervical cancer in developing countries. Vaccine 2006; 24 ( Suppl 3): S3/717.
  • 23
    Parkin DM. The global health burden of infection-associated cancers in the year 2002. Int J Cancer 2006; 118: 303044.
  • 24
    Chen JG,Parkin DM,Chen QG,Lu JH,Shen QJ,Zhang BC,Zhu YR. Screening for liver cancer: results of a randomised controlled trial in Qidong, China. J Med Screen 2003; 10: 2049.
  • 25
    Sankaranarayanan R,Esmy PO,Rajkumar R,Muwonge R,Swaminathan R,Shanthakumari S,Fayette JM,Cherian J. Effect of visual screening on cervical cancer incidence and mortality in Tamil Nadu, India: a cluster-randomised trial. Lancet. 2007; 370: 398406.
  • 26
    Sankaranarayanan R,Ramadas K,Thomas G,Muwonge R,Thara S,Mathew B,Rajan B,Trivandrum Oral Cancer Screening Study Group. Effect of screening on oral cancer mortality in Kerala, India: a cluster-randomised controlled trial. Lancet 2005; 365: 192733.
  • 27
    Yang CS. Research in esophageal cancer in China: a review. Cancer Res 1980; 40: 263344.
  • 28
    Dawsey SM,Lewin KJ,Wang GQ,Liu FS,Nieberg RK,Yu Y,Li JY,Blot WJ,Li B,Taylor PR. Squamous esophageal histology and subsequent risk of squamous cell carcinoma of the esophagus. A prospective follow-up study from Linxian, China. Cancer 1994; 74: 168692.